MAYNE PHARMA FDA Approval ANDA 070686

ANDA 070686

MAYNE PHARMA

FDA Drug Application

Application #070686

Application Sponsors

ANDA 070686MAYNE PHARMA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-280.035MG;0.5MG0NORETHINDRONE AND ETHINYL ESTRADIOLETHINYL ESTRADIOL; NORETHINDRONE

FDA Submissions

ORIG1AP1987-01-29
LABELING; LabelingSUPPL3AP1987-09-28
LABELING; LabelingSUPPL4AP1987-11-19
LABELING; LabelingSUPPL5AP1989-07-28
LABELING; LabelingSUPPL6AP1990-03-15
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-08-10
LABELING; LabelingSUPPL8AP1993-11-04
LABELING; LabelingSUPPL9AP1997-05-01
LABELING; LabelingSUPPL10AP2002-05-08
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2001-08-27
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2001-10-31
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2002-05-21
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2002-06-26
LABELING; LabelingSUPPL37AP2022-04-22STANDARD
LABELING; LabelingSUPPL38AP2022-04-29STANDARD

Submissions Property Types

SUPPL7Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL16Null0
SUPPL37Null15
SUPPL38Null7

TE Codes

001PrescriptionAB

CDER Filings

MAYNE PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70686
            [companyName] => MAYNE PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"NORETHINDRONE AND ETHINYL ESTRADIOL","activeIngredients":"ETHINYL ESTRADIOL; NORETHINDRONE","strength":"0.035MG;0.5MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NORETHINDRONE AND ETHINYL ESTRADIOL","submission":"ETHINYL ESTRADIOL; NORETHINDRONE","actionType":"0.035MG;0.5MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.